title: Epstein-Barr virus-associated lymphoma in patients with dermatomyositis. Be aware of double immunosuppression.
authors.forename: Albert
authors.initials: A
authors.lastname: Selva-O'Callaghan
authors.forename: Andrés
authors.initials: A
authors.lastname: Palacios
authors.forename: Roser
authors.initials: R
authors.lastname: Solans-Laque
authors.forename: Anne
authors.initials: A
authors.lastname: Labirua
authors.forename: Teresa
authors.initials: T
authors.lastname: Salcedo-Allende
authors.forename: Miquel
authors.initials: M
authors.lastname: Vilardell-Tarrés
mesh_terms: D000328:Adult; D003882:Dermatomyositis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008223:Lymphoma / Q000821:virology*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000150:complications*
chemical_list: D007166:Immunosuppressive Agents